BioSpace News Archive

Karolinska Development AB publishes its Q4 and 2018 Year-End Report with a positive quarterly and full-year result. The full report is available on the Company’s website.

Medtronic plc (NYSE:MDT) and the Medical University of South Carolina (MUSC) today announced a five-year value-based health care partnership intended to transform and improve care for patients in South Carolina.

Retrophin, Inc. announced that Eric Dube, Ph.D., chief executive officer, will present at the 8th Annual SVB Leerink Global Healthcare Conference in New York Cityon Thursday, February 28, 2019 at 3:30 p.m. ET.

Two checkpoint inhibitors provide early encouraging results for immunologically cold disease

Gotham Therapeutics, a biotechnology company developing a novel drug class targeting RNA-modifying proteins, today announced the appointment of Carlo Incerti, M.D., Ph.D. as an independent Board Member.

The company believes that the cloth applicator format will provide powerful on-the-go relief for those suffering from excessive sweating.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Miami Cancer Institute, part of Baptist Health South Florida, today announced the implementation of Philips’ IntelliSpace Precision Medicine Genomics in its new state-of-the-art genomics laboratory

Innovative corporate sleep provider dayzz today announced its acceptance to the Philips Healthworks Startup Program, which accelerates breakthrough innovation through internal venturing and external startup engagement.

StemoniX® Inc., a biotech company revolutionizing how new medicines are discovered, announced today that Cassiano Carromeu, PhD, lead neuroscientist at StemoniX, presented research during the SLAS2019 annual meeting demonstrating the ability of microBrain® 3D to produce a functional in vitro disease model for Rett Syndrome (RTT) via human induced Pluripotent Stem Cells (hiPSCs) derived from RTT patients.

Small Business Innovation Research Program Provides Seed Funding for R&D